Precision BioSciences (STU:PBS0) General and Admin. Expense: €26.22 Mil (TTM As of Mar. 2026)


STU:PBS0 Precision BioSciences Inc STU:PBS0
43 GF Score
Price €8.13
GF Value €1.60
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Precision BioSciences General and Admin. Expense?

Precision BioSciences STU:PBS0 43 General and Admin. Expense is €26.22 Mil as of Mar. 2026. GuruFocus rates STU:PBS0 with a GF Score™ of 43/100 and a GF Value™ of €1.60 (Significantly Overvalued). The stock has 5 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Precision BioSciences's General and Admin. Expense for the three months ended in Mar. 2026 was €5.89 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €26.22 Mil.

Precision BioSciences General and Admin. Expense Related Terms

Precision BioSciences General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Precision BioSciences's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precision BioSciences General and Admin. Expense Chart

Precision BioSciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only 35.11 38.97 35.84 33.71 27.53

Precision BioSciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.91 7.91 6.24 6.18 5.89
STU:PBS0
43GF Score
Precision BioSciences Inc STU:PBS0
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precision BioSciences General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €26.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of €26.22 Mil mean?
Precision BioSciences (STU:PBS0) has a General and Admin. Expense of €26.22 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Precision BioSciences and its competitors.
Is Precision BioSciences' General and Admin. Expense too high?
Precision BioSciences' current General and Admin. Expense is €26.22 Mil. Overall, Precision BioSciences has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Precision BioSciences' General and Admin. Expense compare to NBP and HUMA?
Precision BioSciences' General and Admin. Expense of €26.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Precision BioSciences and its competitors. Precision BioSciences's current General and Admin. Expense is €26.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision BioSciences stock overvalued right now?
Based on GuruFocus' analysis, Precision BioSciences (STU:PBS0) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.60, compared to a current price of €8.13 — trading 408.1% above its estimated fair value. The current General and Admin. Expense is €26.22 Mil. Precision BioSciences' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Precision BioSciences (STU:PBS0), the current General and Admin. Expense is €26.22 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precision BioSciences (STU:PBS0) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of €8.13 is trading 408.1% above its estimated GF Value™ of €1.60. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for STU:PBS0:

  • General and Admin. Expense: €26.22 Mil
  • GF Value™: €1.60 vs. price of €8.13 (408.1% above fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the STU:PBS0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision BioSciences Business Description

Other Exchanges DTIL:USA
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
43GF Score

Get the complete analysis for STU:PBS0

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.13
Price
€1.60
GF Value